← Leaderboards
Lilie Leming Lin
University Of Tx Md Anderson Can Ctr
$2,171,805
Attributed
$5,842,669
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,842,669 · 3
By mechanism
R01$5,842,669 · 3
Top collaborators
- Anna Coghill5 shared
- David A Mankoff5 shared
- Susan Citonje Msadabwe5 shared
- David R Piwnica-Worms3 shared
- Sean Denis Carlin2 shared
- Elizabeth Mcdonald2 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Scott Kopetz$13,199,822
- Anil K Sood$29,572,737
- Leland Hu$3,569,147
- Kathleen Marie Schmainda$14,483,193
- Christopher Chad Quarles$12,985,497
Others in their field
Other Emerging Leaders on “Cancer Center”
- Leonard Freedman · Leidos Biomedical Research, Inc.$885,275,552
- Lynn Briscoe · Leidos Biomedical Research, Inc.$248,567,868
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$223,761,604
- Leonard Freedmand · Leidos Biomedical Research, Inc.$185,357,464
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
- Martha Hering · Westat, Inc.$57,098,843
Research focus
Cancer CenterTumorToxic EffectMalignant NeoplasmsCancer PatientFutureSiteClinical DataNovel TherapeuticsDiagnosisBiological MarkersMulticenter TrialsIn VivoImageImaging BiomarkerMalignant Breast NeoplasmBindingDefectClinical TrialsHomologous RecombinationAutoradiographyEpigenetic ProcessCancer TherapyCells
Grant awards (13)
The Impact of Biologic Aging on Immunity-Related Cervical Cancer Outcome Disparities Among Women Living with HIV in Zambia$663,373
R01 · FY2025 · CA · contact PI
Breast Cancer PARP PET Imaging AIP to Support FDA Approval & Commercialization$538,647
R01 · FY2025 · CA
The Impact of Biologic Aging on Immunity-Related Cervical Cancer Outcome Disparities Among Women Living with HIV in Zambia$69,565
R01 · FY2025 · CA · contact PI
The Impact of Biologic Aging on Immunity-Related Cervical Cancer Outcome Disparities Among Women Living with HIV in Zambia$27,888
R01 · FY2025 · CA · contact PI
The Impact of Biologic Aging on Immunity-Related Cervical Cancer Outcome Disparities Among Women Living with HIV in Zambia$760,825
R01 · FY2024 · CA · contact PI
Breast Cancer PARP PET Imaging AIP to Support FDA Approval & Commercialization$538,137
R01 · FY2024 · CA
The Impact of Biologic Aging on Immunity-Related Cervical Cancer Outcome Disparities Among Women Living with HIV in Zambia$666,443
R01 · FY2023 · CA · contact PI
Breast Cancer PARP PET Imaging AIP to Support FDA Approval & Commercialization$597,988
R01 · FY2023 · CA
A novel PARP inhibitor PET tracer for breast cancer$222,661
R01 · FY2023 · CA · contact PI
Breast Cancer PARP PET Imaging AIP to Support FDA Approval & Commercialization$601,217
R01 · FY2022 · CA
A novel PARP inhibitor PET tracer for breast cancer$259,772
R01 · FY2022 · CA · contact PI
Breast Cancer PARP PET Imaging AIP to Support FDA Approval & Commercialization$631,080
R01 · FY2021 · CA
A novel PARP inhibitor PET tracer for breast cancer$265,073
R01 · FY2021 · CA · contact PI